Showing Results for: “type 1 diabetes”

Today, the American Diabetes Association ® and 14 other leading voluntary health organizations and medical societies concerned with diabetes urged the Centers for Disease Control and Prevention (CDC) to consider the health risks people with diabetes are facing with COVID-19 as the agency develops guidance on special patient populations who may benefit from additional COVID-19 vaccine doses. Combined, these groups advocate on behalf of the 122 million Americans with diabetes and prediabetes. This week, it was announced that the Food and Drug Administration (FDA) and CDC will be releasing

In Submission to White House Budget Office, the ADA Lays out Policy Vision for a More Equitable Future for Our Community The American Diabetes Association ® last week submitted comments to the Office of Management and Budget (OMB) in response to a Request for Information (RFI) on the Methods and Leading Practices for Advancing Equity and Support for Underserved Communities Through Government . The submission lays out the ADA’s vision for a safe and healthy future for all Americans–including the 122 million living with diabetes and prediabetes. “The burden of these rising diabetes rates falls

Las nuevas pautas incluyen actualizaciones de las recomendaciones sobre una nueva clase de medicamentos para la obesidad, nuevas prácticas de detección, tecnología para la diabetes y el uso de teplizumab. La Asociación Americana de la Diabetes® (ADA) publicó hoy los Estándares de Cuidado para la Diabetes —2024 ( Estándares de Cuidado ), un conjunto de pautas integrales basadas en evidencia para el manejo de la diabetes tipo 1, tipo 2, diabetes gestacional y prediabetes, según las últimas investigaciones científicas y ensayos clínicos. Incluye estrategias para diagnosticar y tratar la diabetes

The American Diabetes Association announced today it is awarding this year’s prestigious  Pathway to Stop Diabetes  grants, totaling $4.875 million dollars, to three researchers, with each scientist receiving $1.625 million dollars over a five-year grant term to support breakthroughs in basic science, clinical science, technology, care and potential cures in the field of diabetes. Since its inception in 2014, the Pathway program has been an innovative initiative designed to transform diabetes research by attracting brilliant scientists to diabetes research through substantial financial support

Waters Bills Would Eliminate Cost-Sharing for Insulin-Dependent Seniors and Provide Needed Grants for Diabetes Prevention, Care and Treatment The American Diabetes Association® (ADA) announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act (H.R. 2179) and the Minority Diabetes Initiative Act (H.R. 2178), both introduced this week by Representative Maxine Waters (D-CA-43). The ADA calls on all Members of Congress to co-sponsor both pieces of legislation. Currently, both bills have more than 30 cosponsors. The Affordable Insulin for the COVID-19 Emergency Act

Together, we can conquer diabetes and everything that comes with it. #WeStandGreaterThan American Diabetes Month™ (ADM) will kick off next week, and the American Diabetes Association® (ADA) is asking the diabetes community to rise up ! Right now, everything seems to be conspiring to try to make us feel powerless, afraid and small. The non-stop flood of bad news, bleak forecasts and unrelenting heartbreak can be suffocating. Our country is still living through unimaginably tough times and people living with diabetes continue to be severely impacted. During the pandemic, many of the 34 million

People with diabetes are three times as likely to need hospitalization if infected with COVID-19 With the diabetes community at greater risk for complications during the COVID-19 pandemic, the American Diabetes Association® (ADA) and Sun Life partnered to reinvent this year’s annual Call to Congress to educate advocates on COVID-19 and diabetes, and how to support people with diabetes during the pandemic. Usually an in-person gathering of ADA Advocates on Capitol Hill, the recent virtual town hall event informed and engaged the diabetes advocate community about legislative goals specific to

ADA’s advocacy removes barriers so people with insulin-treated diabetes can fly commercial planes Today, the American Diabetes Association (ADA) applauds the Federal Aviation Administration (FAA) for announcing a protocol for pilots with insulin-treated diabetes to obtain the type of certificate needed for commercial flight. In 1959, the FAA banned pilots who use insulin from commercial operations, so today’s move marks a historic day for people with diabetes. “After many years of fighting for the rights of pilots with diabetes at every turn, we are pleased to have broken down a barrier that

The American Diabetes Association ® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic dysfunction and how nutrition formulas can support those needs and overall health. More than 2 in 5 adults in the U.S. are living with obesity and approximately 1 in 10 Americans are living with diabetes, most of which is type 2 diabetes. 1,2 They may have nutritional deficiencies that go undiagnosed, which can have implications on their overall health. Adequate nutrition and nutrition support have shown to